Web Results

www.sec.gov/news/press-release/2012-2012-237htm

Nov 20, 2012 ... Dr. Gilman was selected by Elan Corporation and Wyeth to present the final drug trial results to the public. In phone calls that were arranged by ...

www.sec.gov/litigation/complaints/2012/comp-pr2012-237.pdf

Nov 20, 2012 ... Martoma met Gilman through paid consultations that took place between ... Gilman served as a consultant to Elan and Wyeth from 2003 ..... v. Granting such other and further relief as this Court may deem just and proper.

www.sec.gov/litigation/litreleases/2013/lr22647.htm

Mar 18, 2013 ... Securities and Exchange Commission v. ... was selected by the pharmaceutical companies - Elan Corporation and Wyeth - to present ... The SEC's complaint against CR Intrinsic, Martoma, and Dr. Gilman alleged that during ...

www.crintrinsicfairfund.com

SEC v. CR Intrinsic Investors, LLC. ... suit against CR Intrinsic Investors, LLC (“CR Intrinsic”) and Matthew Martoma and Dr. Sidney Gilman. ... involving the clinical trial results for an Alzheimer's drug being jointly developed by Elan and Wyeth.

www.newyorker.com/magazine/2014/10/13/empire-edge

Oct 13, 2014 ... But in recent years two pharmaceutical companies, Elan and Wyeth, had worked ... By the time Gilman made his presentation, however, S.A.C. Capital no longer owned ...... Martoma was there, wearing a neat V-neck sweater.

www.reuters.com/article/us-sac-martoma/sac-capitals-martoma-found-guilty-of-insider-trading-idUSBREA131TL20140207

Feb 6, 2014 ... ... trial of an Alzheimer's drug being developed by Elan Corp Plc and Wyeth, now owned by Pfizer Inc. ... At trial, prosecutors presented testimony of Gilman and another doctor, Joel Ross, who said they ... The case is U.S. v.

www.lexology.com/library/detail.aspx?g=67e0fa55-ab2c-4938-907a-96beae53d4fa

Aug 29, 2017 ... Martoma extensively consulted Dr. Sidney Gilman - the tipper in this case ... Elan and Wyeth, in his portfolio, and encouraged SAC's principal, ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC2676993

He has served as a consultant for Wyeth, ReNeuron, Adamas, and Kyowa and has grant support from ... Address correspondence and reprint requests to Dr. Sid Gilman, Department of Neurology, ... Colosimo C, Vanacore N, Bonifati V, et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC2864089

In the late 1990s, elan and Wyeth developed an Aβ vaccine for use in humans. ..... Box 4Active versus passive amyloid-β immunization ..... Gilman S, et al.